Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prophase Labs (PRPH)
NASDAQ:PRPH
Holding PRPH?
Track your performance easily
PRPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.44 - $7.48
Previous CloseN/A
Volume469.10K
Average Volume (3M)354.02K
Market Cap
$12.89M
Enterprise Value$74.67M
Total Cash (Recent Filing)$441.00K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.61
Next Earnings
Mar 26, 2025EPS Estimate
-0.24Last Dividend Ex-Date
May 24, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-1.50
Shares Outstanding23,874,030
10 Day Avg. Volume368,658
30 Day Avg. Volume354,016
Standard Deviation0.26
R-Squared0.00397
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market Cap5.79
Enterprise Value/Revenue5.86
Enterprise Value/Gross Profit4.60
Enterprise Value/Ebitda-2.70
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Prophase Labs News
PremiumCompany Announcements
ProPhase Labs: Strategic Moves for Future Growth
Ownership Overview
16.29%
Insiders
3.74% Mutual Funds
0.72% Other Institutional Investors
76.41% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PRPH FAQ
What was Prophase Labs’s price range in the past 12 months?
Prophase Labs lowest stock price was $0.44 and its highest was $7.48 in the past 12 months.
What is Prophase Labs’s market cap?
Prophase Labs’s market cap is $12.89M.
When is Prophase Labs’s upcoming earnings report date?
Prophase Labs’s upcoming earnings report date is Mar 26, 2025 which is in 54 days.
How were Prophase Labs’s earnings last quarter?
Prophase Labs released its earnings results on Nov 13, 2024. The company reported -$0.35 earnings per share for the quarter, missing the consensus estimate of -$0.31 by -$0.04.
Is Prophase Labs overvalued?
According to Wall Street analysts Prophase Labs’s price is currently Overvalued.
Does Prophase Labs pay dividends?
Prophase Labs pays a Annually dividend of $0.3 which represents an annual dividend yield of N/A. See more information on Prophase Labs dividends here
What is Prophase Labs’s EPS estimate?
Prophase Labs’s EPS estimate is -0.24.
How many shares outstanding does Prophase Labs have?
Prophase Labs has 23,874,030 shares outstanding.
What happened to Prophase Labs’s price movement after its last earnings report?
Prophase Labs reported an EPS of -$0.35 in its last earnings report, missing expectations of -$0.31. Following the earnings report the stock price went up 4.054%.
Which hedge fund is a major shareholder of Prophase Labs?
Currently, no hedge funds are holding shares in PRPH
---
Company Description
Prophase Labs
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.
---
PRPH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted several growth initiatives and product launches, particularly in the DNA and pharmaceutical sectors, indicating optimism for future growth. However, challenges with delayed government receivables and cash flow imbalances highlight ongoing financial concerns.Read More>---
Technical Analysis
---